Close Window

Digital Look Email A Friend

AstraZeneca's Forziga recommended for EU use

Published by Frank Prenesti on 19th December 2022

(Sharecast News) - AstraZeneca's Forxiga drug has been recommended for approval in the EU for symptomatic chronic heart failure, the pharma company said on Monday.

URL: http://www.digitallook.com/dl/news/story/33186419/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.